Juan A Riesco1, María Hidalgo2, David Chipayo3, José J Gómez3, Fernando Zaragozá4. 1. Pulmonology Department, CIBER de Enfermedades Respiratorias (CIBERES), University Hospital of Cáceres, Cáceres, Spain. jantonio.riesco@gmail.com. 2. Pulmonology Department, University Hospital La Paz, Madrid, Spain. 3. Cardiology Department, University Hospital of Cáceres, Cáceres, Spain. 4. Medical Department Rovi Labs, Madrid, Spain.
Abstract
INTRODUCTION: Cardiovascular diseases (CVDs) and chronic obstructive pulmonary disease (COPD) have similar prevalence rates and risk factors, and both frequently occur in the same patient. The primary objective of the study was to evaluate the rate of COPD patients among subjects with some form of CVD referring to a smoking cessation unit. The secondary objective was to analyze the demographic and clinical profile of these subjects and to identify independent factors potentially associated with COPD. METHODS: Observational, prospective study involving 132 patients with smoking habits, and some form of CVD, referring to the smoking cessation unit at the Pulmonology Department of the University Hospital of Cáceres, Spain, between October 2015 and March 2017. RESULTS: A total of 58 patients (43.9%) were diagnosed with COPD. Main CVDs were: ischemic heart disease (76.5%), chronic heart failure (24.8%), peripheral arterial disease (18.5%), and atrial fibrillation (7.6%). Independent factors were: pack-years (> 30 versus < 30; odds ratio, OR 5.3; 95% CI 1.3-21.4); forced expiratory volume in the first second (OR 0.9; 95% CI 0.9-1.0); chronic heart failure (yes versus no; OR 4.7; 95% CI 1.3-16.4); and modified Medical Research Council (mMRC) dyspnea (2-3 versus 0; OR 18.7; 95% CI 1.9-182.0). CONCLUSIONS: Four of ten patients with some form of CVD also experience COPD. Dyspnea, airflow limitation, smoking habits, and chronic heart failure were significant factors associated with COPD in patients with CVD. Smoking cessation units are useful to improve the diagnosis of COPD in these patients. Further prospective studies with a greater cohort of patients are required to corroborate the present results and to enhance the knowledge of the clinical profile of these patients.
INTRODUCTION: Cardiovascular diseases (CVDs) and chronic obstructive pulmonary disease (COPD) have similar prevalence rates and risk factors, and both frequently occur in the same patient. The primary objective of the study was to evaluate the rate of COPD patients among subjects with some form of CVD referring to a smoking cessation unit. The secondary objective was to analyze the demographic and clinical profile of these subjects and to identify independent factors potentially associated with COPD. METHODS: Observational, prospective study involving 132 patients with smoking habits, and some form of CVD, referring to the smoking cessation unit at the Pulmonology Department of the University Hospital of Cáceres, Spain, between October 2015 and March 2017. RESULTS: A total of 58 patients (43.9%) were diagnosed with COPD. Main CVDs were: ischemic heart disease (76.5%), chronic heart failure (24.8%), peripheral arterial disease (18.5%), and atrial fibrillation (7.6%). Independent factors were: pack-years (> 30 versus < 30; odds ratio, OR 5.3; 95% CI 1.3-21.4); forced expiratory volume in the first second (OR 0.9; 95% CI 0.9-1.0); chronic heart failure (yes versus no; OR 4.7; 95% CI 1.3-16.4); and modified Medical Research Council (mMRC) dyspnea (2-3 versus 0; OR 18.7; 95% CI 1.9-182.0). CONCLUSIONS: Four of ten patients with some form of CVD also experience COPD. Dyspnea, airflow limitation, smoking habits, and chronic heart failure were significant factors associated with COPD in patients with CVD. Smoking cessation units are useful to improve the diagnosis of COPD in these patients. Further prospective studies with a greater cohort of patients are required to corroborate the present results and to enhance the knowledge of the clinical profile of these patients.
Authors: Truls S Ingebrigtsen; Jacob L Marott; Jørgen Vestbo; Jesper Hallas; Børge G Nordestgaard; Morten Dahl; Peter Lange Journal: Chest Date: 2013-12 Impact factor: 9.410
Authors: Martin C S Wong; Jing Liu; Shenglai Zhou; Shiwei Li; Xuefen Su; Harry H X Wang; Roger Y N Chung; Benjamin H K Yip; Samuel Y S Wong; Joseph T F Lau Journal: Int J Cardiol Date: 2014-09-28 Impact factor: 4.164
Authors: Bernd Lamprecht; Joan B Soriano; Michael Studnicka; Bernhard Kaiser; Lowie E Vanfleteren; Louisa Gnatiuc; Peter Burney; Marc Miravitlles; Francisco García-Rio; Kaveh Akbari; Julio Ancochea; Ana M Menezes; Rogelio Perez-Padilla; Maria Montes de Oca; Carlos A Torres-Duque; Andres Caballero; Mauricio González-García; Sonia Buist Journal: Chest Date: 2015-10 Impact factor: 9.410
Authors: Jadwiga A Wedzicha; Peter M A Calverley; Richard K Albert; Antonio Anzueto; Gerard J Criner; John R Hurst; Marc Miravitlles; Alberto Papi; Klaus F Rabe; David Rigau; Pawel Sliwinski; Thomy Tonia; Jørgen Vestbo; Kevin C Wilson; Jerry A Krishnan Journal: Eur Respir J Date: 2017-09-09 Impact factor: 16.671
Authors: Miguel Divo; Claudia Cote; Juan P de Torres; Ciro Casanova; Jose M Marin; Victor Pinto-Plata; Javier Zulueta; Carlos Cabrera; Jorge Zagaceta; Gary Hunninghake; Bartolome Celli Journal: Am J Respir Crit Care Med Date: 2012-05-03 Impact factor: 21.405
Authors: Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie Journal: Lancet Date: 2012-05-10 Impact factor: 79.321
Authors: Claus F Vogelmeier; Gerard J Criner; Fernando J Martínez; Antonio Anzueto; Peter J Barnes; Jean Bourbeau; Bartolome R Celli; Rongchang Chen; Marc Decramer; Leonardo M Fabbri; Peter Frith; David M G Halpin; M Victorina López Varela; Masaharu Nishimura; Nicolás Roche; Roberto Rodríguez-Roisin; Don D Sin; Dave Singh; Robert Stockley; Jørgen Vestbo; Jadwiga A Wedzicha; Alvar Agustí Journal: Arch Bronconeumol Date: 2017-03-06 Impact factor: 4.872
Authors: Sandra H van Oostrom; H Susan J Picavet; Simone R de Bruin; Irina Stirbu; Joke C Korevaar; Francois G Schellevis; Caroline A Baan Journal: BMC Fam Pract Date: 2014-04-07 Impact factor: 2.497